528 related articles for article (PubMed ID: 27855634)
21. Renoprotective effect of curcumin against the combined oxidative stress of diabetes and nicotine in rats.
Ibrahim ZS; Alkafafy ME; Ahmed MM; Soliman MM
Mol Med Rep; 2016 Apr; 13(4):3017-26. PubMed ID: 26936435
[TBL] [Abstract][Full Text] [Related]
22. Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies.
Gholaminejad A; Abdul Tehrani H; Gholami Fesharaki M
J Nephrol; 2018 Dec; 31(6):813-831. PubMed ID: 30019103
[TBL] [Abstract][Full Text] [Related]
23. Diabetes-induced upregulation of kallistatin levels exacerbates diabetic nephropathy via RAS activation.
Yang Y; He X; Cheng R; Chen Q; Shan C; Chen L; Ma JX
FASEB J; 2020 Jun; 34(6):8428-8441. PubMed ID: 32352602
[TBL] [Abstract][Full Text] [Related]
24. Transcriptome-based analysis of kidney gene expression changes associated with diabetes in OVE26 mice, in the presence and absence of losartan treatment.
Komers R; Xu B; Fu Y; McClelland A; Kantharidis P; Mittal A; Cohen HT; Cohen DM
PLoS One; 2014; 9(5):e96987. PubMed ID: 24827579
[TBL] [Abstract][Full Text] [Related]
25. Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy.
Mafi A; Yadegar N; Salami M; Salami R; Vakili O; Aghadavod E
Pathol Res Pract; 2021 Nov; 227():153618. PubMed ID: 34649056
[TBL] [Abstract][Full Text] [Related]
26. Deciphering the role of MicroRNAs in diabetic nephropathy: Regulatory mechanisms and molecular insights.
Abdelmaksoud NM; Al-Noshokaty TM; Abdelhamid R; Abdellatif N; Mansour A; Mohamed R; Mohamed AH; Khalil NAE; Abdelhamid SS; Mohsen A; Abdelaal H; Tawfik A; Elshaer SS
Pathol Res Pract; 2024 Apr; 256():155237. PubMed ID: 38492358
[TBL] [Abstract][Full Text] [Related]
27. Long-term expression of glomerular genes in diabetic nephropathy.
Chittka D; Banas B; Lennartz L; Putz FJ; Eidenschink K; Beck S; Stempfl T; Moehle C; Reichelt-Wurm S; Banas MC
Nephrol Dial Transplant; 2018 Sep; 33(9):1533-1544. PubMed ID: 29340699
[TBL] [Abstract][Full Text] [Related]
28. DNA Methylome and Transcriptome Alterations in High Glucose-Induced Diabetic Nephropathy Cellular Model and Identification of Novel Targets for Treatment by Tanshinone IIA.
Li W; Sargsyan D; Wu R; Li S; Wang L; Cheng D; Kong AN
Chem Res Toxicol; 2019 Oct; 32(10):1977-1988. PubMed ID: 31525975
[TBL] [Abstract][Full Text] [Related]
29. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
Eissa S; Matboli M; Bekhet MM
Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
[TBL] [Abstract][Full Text] [Related]
30. Arginase-2 mediates diabetic renal injury.
Morris SM; Gao T; Cooper TK; Kepka-Lenhart D; Awad AS
Diabetes; 2011 Nov; 60(11):3015-22. PubMed ID: 21926276
[TBL] [Abstract][Full Text] [Related]
31. Differential Gene Expression in Diabetic Nephropathy in Individuals With Type 1 Diabetes.
Caramori ML; Kim Y; Goldfine AB; Moore JH; Rich SS; Mychaleckyj JC; Kirkpatrick D; Nickerson H; Krolewski AS; Mauer M
J Clin Endocrinol Metab; 2015 Jun; 100(6):E876-82. PubMed ID: 25871838
[TBL] [Abstract][Full Text] [Related]
32. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
33. Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease.
Brennan EP; Mohan M; McClelland A; Tikellis C; Ziemann M; Kaspi A; Gray SP; Pickering R; Tan SM; Ali-Shah ST; Guiry PJ; El-Osta A; Jandeleit-Dahm K; Cooper ME; Godson C; Kantharidis P
J Am Soc Nephrol; 2018 May; 29(5):1437-1448. PubMed ID: 29490938
[No Abstract] [Full Text] [Related]
34. Comparative RNA-Seq transcriptome analyses reveal distinct metabolic pathways in diabetic nerve and kidney disease.
Hinder LM; Park M; Rumora AE; Hur J; Eichinger F; Pennathur S; Kretzler M; Brosius FC; Feldman EL
J Cell Mol Med; 2017 Sep; 21(9):2140-2152. PubMed ID: 28272773
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression.
Fan Y; Yi Z; D'Agati VD; Sun Z; Zhong F; Zhang W; Wen J; Zhou T; Li Z; He L; Zhang Q; Lee K; He JC; Wang N
Diabetes; 2019 Dec; 68(12):2301-2314. PubMed ID: 31578193
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of microRNAs associated with neurodegenerative diseases and diabetic nephropathy in protein l-isoaspartyl methyltransferase-deficient mice.
Su Z; Ren N; Ling Z; Sheng L; Zhou S; Guo C; Ke Z; Xu T; Qin Z
Cell Biol Int; 2021 Nov; 45(11):2316-2330. PubMed ID: 34314072
[TBL] [Abstract][Full Text] [Related]
37. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
Ge J; Miao JJ; Sun XY; Yu JY
J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling in glomeruli of diabetic nephropathy rat.
Zhang Q; Xiao X; Li M; Li W; Yu M; Zhang H; Sun X; Mao L; Xiang H
Exp Biol Med (Maywood); 2012 Aug; 237(8):903-11. PubMed ID: 22903132
[TBL] [Abstract][Full Text] [Related]
39. Anti-inflammatory effects of a synthetic peptide derived from pigment epithelium-derived factor on H₂O₂-induced corneal injury in vitro.
Lu Y; Feng J; Yang L; Tang H; Jin J; Xu X
Chin Med J (Engl); 2014; 127(8):1438-44. PubMed ID: 24762585
[TBL] [Abstract][Full Text] [Related]
40. Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets.
Hojjati F; Roointan A; Gholaminejad A; Eshraghi Y; Gheisari Y
Nefrologia (Engl Ed); 2023; 43(5):575-586. PubMed ID: 36681521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
